Pazopanib 200mg, 400mg Tablets
Pazopanib 200mg,400mg tablets are designed for the treatment of symptoms of soft tissue sarcomas. These sarcomas are a type of cancer cell that proliferate swiftly in the body. the medication comes under the brand name of Votrient.
Votrient tablets belong to the class of drugs called antineoplastics, VEGF inhibitors, and kinase inhibitors. The tablets interfere with the growth process of cancer cells and hence, control the growth of cancer cells.
Some kind of interactive reactions is seen with these tablets such as CYP3A, that interfere with the reactions of these tablets.
1. What is Votrient (Pazopanib) used for?
Votrient contains pazopanib, an oral kinase inhibitor used for the treatment of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in adults who have previously received chemotherapy. The specific indication and treatment regimen depend on the applicable regulatory approval and clinical assessment.
2. How does Votrient (Pazopanib) work?
Votrient works by inhibiting several receptor tyrosine kinases, including pathways involving vascular endothelial growth factor receptors (VEGFR). By interfering with signaling involved in tumor-cell growth and angiogenesis, pazopanib can help slow the growth and development of certain cancers.
3. What strengths of Votrient tablets are available?
Lotus International lists Pazopanib 200 mg and 400 mg tablets on its Votrient product page. The current U.S. Votrient prescribing information specifies 200 mg tablets; presentations and strengths can vary by manufacturer and market. International buyers should confirm the required strength, packaging, and availability with Lotus International before placing an order.
4. How is Votrient administered?
Votrient is an oral tablet. The current U.S. prescribing information recommends 800 mg once daily without food, taken at least 1 hour before or 2 hours after a meal, for the labeled adult indications. Tablets should be swallowed whole rather than crushed. Dose adjustments may be required based on hepatic impairment, drug interactions, or treatment-related adverse reactions. Treatment should be prescribed and monitored by a qualified healthcare professional.
5. Can international buyers source Votrient from Lotus International?
International pharmaceutical importers, distributors, wholesalers, hospitals, and procurement organizations can contact Lotus International regarding Votrient (Pazopanib) supply. Buyers can enquire about product availability, required quantities, packaging, documentation, and export requirements for international pharmaceutical procurement. Lotus International lists Votrient under its Anti Cancer product category.